# Nuclide record usb-basel (institution). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/institutions/usb-basel/>
  a schema:MedicalOrganization ;
  nuclide:kind "institution" ;
  schema:identifier "usb-basel" ;
  schema:name "University Hospital Basel / Tumour Centre"@en ;
  schema:alternateName "USB"@en, "Universitätsspital Basel"@en, "Tumorzentrum Basel"@en ;
  schema:description "University Hospital Basel coordinates cancer care in the home city of Roche and Novartis; its groups run early-phase tumour immunology trials, study breast cancer metastasis, and develop peptide radioligands such as exendin-based imaging of insulinomas."@en ;
  schema:url <https://nuclide.cc/institutions/usb-basel/>, <https://www.unispital-basel.ch/en/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://www.unispital-basel.ch/en/>, <https://www.unispital-basel.ch/en/tumorzentrum> ;
  schema:addressCountry "CH" ;
  schema:addressLocality "Basel" ;
  schema:latitude "47.561"^^xsd:decimal ;
  schema:longitude "7.582"^^xsd:decimal ;
  nuclide:indications <https://nuclide.cc/indications/neuroendocrine/> ;
  nuclide:technologies <https://nuclide.cc/technologies/radioligand-therapy/>, <https://nuclide.cc/technologies/pet-ct/> ;
  nuclide:companies <https://nuclide.cc/companies/novartis/> ;
  nuclide:institutions <https://nuclide.cc/institutions/inselspital-bern/>, <https://nuclide.cc/institutions/usz-zurich/> .
